CD14 and TLR4 mediate cytokine release promoted by electronegative LDL in monocytes

Atherosclerosis

Volumn 229, Issue 2, 2013, Pages 356-362

  Estruch, Montserrat ^a,b   Bancells, Cristina ^a,b   Beloki, Lorea ^b   Sanchez Quesada, Jose Luis ^a   Ordóñez Llanos, Jordi ^b,c   Benitez, Sonia ^a  

^a BIOMEDICAL RESEARCH INSTITUTE SANT PAU IIB SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

CD14; Electronegative LDL; Lipopolysaccharide; Monocytes; Toll like receptors

Indexed keywords

CD14 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTRALIZING ANTIBODY; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CIRCULATION; CONTROLLED STUDY; CYTOKINE RELEASE; GENE SILENCING; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

CD14; ELECTRONEGATIVE LDL; LIPOPOLYSACCHARIDE; MONOCYTES; TOLL-LIKE RECEPTORS;

ANTIBODIES, NEUTRALIZING; ANTIGENS, CD14; BINDING, COMPETITIVE; CYTOKINES; HUMANS; LIPOPOLYSACCHARIDES; LIPOPROTEINS, LDL; MONOCYTES; NF-KAPPA B; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION FACTOR AP-1;

EID: 84880413149     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.05.011     Document Type: Article

References (31)

1. Sabroe I., Read R.C., Whyte M.K., et al. Toll-like receptors in health and disease: complex questions remain. JImmunol 2003, 171:1630-1635.
2. Liew F.Y., Xu D., Brint E.K., et al. Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol 2005, 5:446-458.
3. Schoneveld A.H., Hoefer I., Sluijter J.P., et al. Atherosclerotic lesion development and Toll like receptor 2 and 4 responsiveness. Atherosclerosis 2008, 197:95-104.
4. Cole J.E., Georgiou E., Monaco C. The expression and functions of toll-like receptors in atherosclerosis. Mediators Inflamm 2010, 2010:393946.
5. Dentener M.A., Bazil V., Von Asmuth E.J., et al. Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-alpha, IL-6 and IL-8 release by human monocytes and alveolar macrophages. JImmunol 1993, 150:2885-2891.
6. Binder C.J., Shaw P.X., Chang M.K., et al. The role of natural antibodies in atherogenesis. JLipid Res 2005, 46:1353-1363.
7. Miller Y.I., Chang M.K., Binder C.J., et al. Oxidized low density lipoprotein and innate immune receptors. Curr Opin Lipidol 2003, 14:437-445.
8. Miller Y.I., Viriyakosol S., Worrall D.S., et al. Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages. Arterioscler Thromb Vasc Biol 2005, 25:1213-1219.
9. Chavez-Sanchez L., Chavez-Rueda K., Legorreta-Haquet M.V., et al. The activation of CD14, TLR4, and TLR2 by mmLDL induces IL-1beta, IL-6, and IL-10 secretion in human monocytes and macrophages. Lipids Health Dis 2010, 9:117.
10. Choi S.H., Harkewicz R., Lee J.H., et al. Lipoprotein accumulation in macrophages via toll-like receptor-4-dependent fluid phase uptake. Circ Res 2009, 104:1355-1363.
11. Schmitz G., Orso E. CD14 signalling in lipid rafts: new ligands and co-receptors. Curr Opin Lipidol 2002, 13:513-521.
12. Sanchez-Quesada J.L., Benitez S., Ordonez-Llanos J. Electronegative low-density lipoprotein. Curr Opin Lipidol 2004, 15:329-335.
13. Benitez S., Camacho M., Arcelus R., et al. Increased lysophosphatidylcholine and non-esterified fatty acid content in LDL induces chemokine release in endothelial cells. Relationship with electronegative LDL. Atherosclerosis 2004, 177:299-305.
14. Benitez S., Sanchez-Quesada J.L., Ribas V., et al. Platelet-activating factor acetylhydrolase is mainly associated with electronegative low-density lipoprotein subfraction. Circulation 2003, 108:92-96.
15. Bancells C., Benitez S., Villegas S., et al. Novel phospholipolytic activities associated with electronegative low-density lipoprotein are involved in increased self-aggregation. Biochemistry 2008, 47:8186-8194.
16. Bancells C., Benitez S., Ordonez-Llanos J., et al. Immunochemical analysis of the electronegative LDL subfraction shows that abnormal n-terminal apolipoprotein B conformation is involved in increased binding to proteoglycans. JBiol Chem 2011, 286:1125-1133.
17. Benitez S., Camacho M., Bancells C., et al. Wide proinflammatory effect of electronegative low-density lipoprotein on human endothelial cells assayed by a protein array. Biochim Biophys Acta 2006, 1761:1014-1021.
18. Benitez S., Bancells C., Ordonez-Llanos J., et al. Pro-inflammatory action of LDL(-) on mononuclear cells is counteracted by increased IL10 production. Biochim Biophys Acta 2007, 1771:613-622.
19. Bancells C., Sánchez-Quesada J.L., Birkelund R., et al. Electronegative LDL induces Fas and modifies gene expression in mononuclear cells. Front Biosci 2010, 2:78-86. [Elite Ed].
20. Bancells C., Sanchez-Quesada J.L., Birkelund R., et al. HDL and electronegative LDL exchange anti- and pro-inflammatory properties. JLipid Res 2010, 51:2947-2956.
21. Benitez S., Villegas V., Bancells C., et al. Impaired binding affinity of electronegative low-density lipoprotein (LDL) to the LDL receptor is related to nonesterified fatty acids and lysophosphatidylcholine content. Biochemistry 2004, 43:15863-15872.
22. Tang D., Lu J., Walterscheid J.P., et al. Electronegative LDL circulating in smokers impairs endothelial progenitor cell differentiation by inhibiting Akt phosphorylation via LOX-1. JLipid Res 2008, 49:33-47.
23. Dziarski R., Tapping R.I., Tobias P.S. Binding of bacterial peptidoglycan to CD14. JBiol Chem 1998, 273:8680-8690.
24. Landmann R., Link S., Sansano S., et al. Soluble CD14 activates monocytic cells independently of lipopolysaccharide. Infect Immun 1998, 66:2264-2271.
25. Sweet M.J., Hume D.A. Endotoxin signal transduction in macrophages. JLeukoc Biol 1996, 60:8-26.
26. Kitchens R.L., Thompson P.A., Viriyakosol S., et al. Plasma CD14 decreases monocyte responses to LPS by transferring cell-bound LPS to plasma lipoproteins. JClin Invest 2001, 108:485-493.
27. Hamilton T.A., Ma G.P., Chisolm G.M. Oxidized low density lipoprotein suppresses the expression of tumor necrosis factor-alpha mRNA in stimulated murine peritoneal macrophages. JImmunol 1990, 144:2343-2350.
28. Wiesner P., Choi S.H., Almazan F., et al. Low doses of lipopolysaccharide and minimally oxidized low-density lipoprotein cooperatively activate macrophages via nuclear factor kappa B and activator protein-1: possible mechanism for acceleration of atherosclerosis by subclinical endotoxemia. Circ Res 2010, 107:56-65.
29. Weinstock C., Ullrich H., Hohe R., et al. Low density lipoproteins inhibit endotoxin activation of monocytes. Arterioscler Thromb 1992, 12:341-347.
30. Mironova M.A., Klein R.L., Virella G.T., et al. Anti-modified LDL antibodies, LDL-containing immune complexes, and susceptibility of LDL to invitro oxidation in patients with type 2 diabetes. Diabetes 2000, 49:1033-1041.
31. Pedrosa A.M., Faine L.A., Grosso D.M., et al. Electronegative LDL induction of apoptosis in macrophages: involvement of Nrf2. Biochim Biophys Acta 2010, 1801:430-437.